StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin (BMRN) Reiterates Profitability in 2017 - Piper Jaffray
February 26, 2016 9:46 AM
Piper Jaffray analyst, Joshua Schimmer, sees numerous catalysts for BioMarin (NASDAQ: BMRN) as the company marches toward profitability ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
BioMarin Pharma (BMRN) Misses Q4 EPS Views
February 25, 2016 4:04 PM
BioMarin Announces Fourth Quarter and Full Year 2015 Financial Results
February 25, 2016 4:02 PM